Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
BEAM Quote, Financials, Valuation and Earnings
Last price:
$20.45
Seasonality move
:
-4.64%
Day range:
$19.66 - $20.51
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.48x
P/B ratio:
1.80x
Volume:
2.1M
Avg. volume:
2.2M
1-year change:
-26.46%
Market cap:
$2B
Revenue:
$63.5M
EPS (TTM):
-$4.61
Earnings Data
Next earnings date for BEAM
Aug 06
2025
Most recent earnings per share
-$1.24
Missed by $0.07
(May 6/2025)
Consensus Estimate
-$1.17
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BEAM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $14.6M | -- | -- | -$1.09 | -- |
| 08/06/2025 | Q2 | $13.3M | -- | -- | -$1.09 | -- |
| 05/06/2025 | Q1 | $14.7M | $7.5M | -$1.24 | -$1.17 | -$0.07 |
| 02/25/2025 | Q4 | $16.5M | $30.1M | -$1.09 | -$1.22 | $0.13 |
| 11/05/2024 | Q3 | $14.1M | $14.3M | -$1.17 | -$1.18 | $0.01 |
| 08/06/2024 | Q2 | $13M | $11.8M | -$1.11 | -$1.12 | $0.01 |
| 05/07/2024 | Q1 | $14.7M | $7.4M | -$1.21 | -$1.39 | $0.18 |
| 02/27/2024 | Q4 | $33.7M | $316.2M | $1.73 | -$0.71 | $2.44 |
| 11/08/2023 | Q3 | -- | -- | -$1.22 | -$1.27 | $0.05 |
| 08/08/2023 | Q2 | -- | -- | -$1.08 | -$1.38 | $0.30 |
| 05/10/2023 | Q1 | -- | -- | -$1.33 | -$1.30 | -$0.03 |
| 02/28/2023 | Q4 | -- | -- | -$0.54 | -$1.34 | $0.80 |
| 11/07/2022 | Q3 | -- | -- | -$1.56 | -$1.09 | -$0.47 |
| 08/09/2022 | Q2 | -- | -- | -$1.02 | -$1.02 | $0.00 |
| 05/09/2022 | Q1 | -- | -- | -$1.01 | -$1.34 | $0.33 |
| 02/28/2022 | Q4 | -- | -- | -$0.95 | -$0.94 | -$0.01 |
| 11/08/2021 | Q3 | -- | -- | -$0.42 | -$0.72 | $0.30 |
| 08/10/2021 | Q2 | -- | -- | -$1.23 | -$0.74 | -$0.49 |
| 05/11/2021 | Q1 | -- | -- | -$3.35 | -$0.75 | -$2.60 |
| 03/30/2021 | Q4 | -- | -- | -$1.88 | -$0.68 | -$1.20 |
| 11/10/2020 | Q3 | -- | -- | -$0.69 | -$0.54 | -$0.15 |
| 08/12/2020 | Q2 | -- | -- | -$0.69 | -$0.51 | -$0.18 |
| 05/12/2020 | Q1 | -- | -- | -$1.03 | -$0.48 | -$0.55 |
| 03/30/2020 | Q4 | -- | -- | -$0.69 | -$0.49 | -$0.20 |
| 09/30/2019 | Q3 | -- | -- | -$0.63 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.60 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.47 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.75 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$2.00 | -- | -- |
Beam Therapeutics Earnings Questions
-
How Much did Beam Therapeutics Generate in Revenue Last Quarter?
Beam Therapeutics reported $7.5M worth of top line sales in its most recent quarter.
-
Did Beam Therapeutics Beat Earnings Last Quarter?
Beam Therapeutics announced earnings per share of -$1.24 which represents a miss of analyst forecast a -$1.17 per share.
-
Is Beam Therapeutics Profitable?
Beam Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Beam Therapeutics EPS Next Year?
Beam Therapeutics's earnings are forecast to decrease from -$4.58 per share to -$4.68 per share next year representing a decrease of -0.79%.
-
When is Beam Therapeutics's Earnings Date?
Beam Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
